|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Factor IX Activity, Clotting
Test CodeCPT Codes
85250<br>Limited Access Code
Preferred Specimen
Minimum Volume
Instructions
Refer to Quest Diagnostics Directory of Services under Specimen Collection section, Coagulation Testing for further information on specimen processing.
Transport Temperature
Specimen Stability
Refrigerated: Unacceptable
Frozen -20° C: 14 days
Frozen -70° C: 1 year
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Photometric Clot Detection
Setup Schedule
Reference Range
Clinical Significance
This assay measures the activity of coagulation FIX in plasma. Individuals with FIX activity <50% have hemophilia B, a condition marked by episodes of excessive or unexplained bleeding that affects all races and ethnic groups equally. Indications for FIX testing include a personal history of excessive or unexplained bleeding and family history of hemophilia B [1,2].
FIX deficiency is an X-linked condition that mainly affects boys and men, though a small percentage of those affected are women, who may be asymptomatic carriers or have very mild symptoms. Therefore, FIX testing may be appropriate for pregnant women with a family history of hemophilia B. Although FIX deficiency is generally considered an inherited
condition, approximately one-third of cases are caused by spontaneous genetic mutations. [1,2] Severe cases of hemophilia B (FIX<1%) may become evident in early infancy, when boys bleed excessively after circumcision. However, moderate (FIX 6% to 49%) and mild (FIX 1% to 5%) cases may remain undiagnosed until excessive bleeding is noted following trauma, injury, or surgery [1,2].
References
1. AACC. Coagulation factors. https://labtestsonline.org/tests/coagulation-factors. Accessed October 2, 2019.
2. National Hemophilia Foundation. Hemophilia V. https://www.hemophilia.org/Bleeding-Disorders/Types-of-Bleeding-Disorders/Hemophilia-B. Accessed October 2, 2019.